This review synthesises methodological lessons from ketamine studies to recommend how clinical trials can be adapted to evaluate rapid reductions in suicidal ideation, emphasising rapid outcome measurement and embedding psychological and neurobiological markers. The authors propose these approaches as a blueprint for testing rapid‑acting pharmacological or psychotherapeutic interventions for suicidal thoughts.
- Published
- Journal
- Suicide and Life-Threatening Behavior
- Authors
- Ballard, E. D., Farmer, C. A., Fields, J., Zarate, C. A.